Compare AKBA & INSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKBA | INSE |
|---|---|---|
| Founded | 2007 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.0M | 206.2M |
| IPO Year | 2014 | 2014 |
| Metric | AKBA | INSE |
|---|---|---|
| Price | $1.21 | $7.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.67 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 5.7M | 149.9K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $199,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.25 |
| 52 Week Low | $0.82 | $6.11 |
| 52 Week High | $4.08 | $9.95 |
| Indicator | AKBA | INSE |
|---|---|---|
| Relative Strength Index (RSI) | 65.77 | 50.40 |
| Support Level | $1.16 | $7.52 |
| Resistance Level | $1.56 | $8.42 |
| Average True Range (ATR) | 0.08 | 0.38 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 87.69 | 32.29 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.